Zenobia Therapeutics (United States)

Recent papers from Zenobia Therapeutics (United States)

1. Expecting medication misuse: a proactive approach to drug discovery to prevent fatal overdoseFuture Medicinal Chemistry · 2025
2. Neutralization of NET-associated human ARG1 enhances cancer immunotherapyScience Translational Medicine · 2023
3. Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injuryProceedings of the National Academy of Sciences · 2017
4. Cysteine Specific Targeting of the Functionally Distinct Peroxiredoxin and Glutaredoxin Proteins by the Investigational Disulfide BNP7787Molecules · 2015
5. Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787OncoTargets and Therapy · 2015
6. Identification and Optimization of PDE10A Inhibitors Using Fragment-Based Screening by Nanocalorimetry and X-ray CrystallographySLAS DISCOVERY · 2013
7. Structure determination of LpxD from the lipopolysaccharide-synthesis pathway ofAcinetobacter baumanniiActa Crystallographica Section F Structural Biology and Crystallization Communications · 2012
8. Fragment-Based Screening for Inhibitors of PDE4A Using Enthalpy Arrays and X-ray CrystallographySLAS DISCOVERY · 2012
9. Crystallographic Fragment Screening2011
10. The structure of LpxD fromPseudomonas aeruginosaat 1.3 Å resolutionActa Crystallographica Section F Structural Biology and Crystallization Communications · 2011
11. X-ray Crystal Structures of Monomeric and Dimeric Peptide Inhibitors in Complex with the Human Neonatal Fc Receptor, FcRnJournal of Biological Chemistry · 2010
12. The pressure transformation from a diffuse sound field to the external ear and to the body and head surfaceThe Journal of the Acoustical Society of America · 1979